Antiseptic and antimicrobial treatment of burns can lead to bacterial infections, according to a study published in the Journal of Medical Informatics.

The authors of the study say it is the first to assess the antimicrobial effect of antibacterial agents.

“It is well established that bacteria are the major contributors to infectious diseases, but only in some infections can they be controlled,” said study co-author Daniel Kranz, a physician at the University of Vienna.

“In a new study, we have shown that antibiotics and antisepsis can be used together in combination to treat bacterial infections in patients who have had bacterial infections with severe burning and to decrease the rate of infections in the general population,” he said.

The research is based on data collected by a group of doctors in Austria.

The study involved the use of a new type of antibiotics known as metronidazole and a new antibacterial agent called a piperacillin.

Antibiotics are drugs that kill or stop a bacterial infection in order to kill it in its source.

Antiseptic agents are chemicals that destroy the bacteria’s outer membrane.

Antibacterial agents have a different function.

They kill the bacteria by disrupting their internal network, which allows it to grow and survive.

They are often used in hospitals, where bacteria cause infections in both people and animals.

“The antimicrobial agents we used are very good for the bacterial infection because they destroy the inner membrane of the bacteria, and the outer membrane is the most important part of the bacterial cell,” said Kranzz.

The antibacterial effect of the antibiotics was measured by comparing the bacterial growth rate in the skin of two patients with severe burns, a group with similar bacterial infections.

Both patients had been treated with antibiotics for several weeks.

In the first trial, the skin samples were taken before and after treatment with antibiotics.

In the second trial, after four days of antibiotic treatment, both patients had a bacterial growth in their skin that was similar to that in the first study.

“We found that after four months of treatment, there was a very small decrease in the growth of the skin in both patients, but the growth rate increased significantly,” Kranzi said.

In addition to the antibiotics, the researchers used a pheromone called piperapis to track bacterial growth.

They then used this information to compare the bacterial counts in both the skin and in the blood.

The results showed that antibiotic treatment of both patients significantly reduced the bacterial count in both skin and blood samples.

The researchers also found that the bacteria were also less likely to cause infections when the antibiotic was administered before or after a hospitalization.

The paper also reports that a study of patients who had had severe burns that resulted in severe inflammation of the upper respiratory tract found that antibiotics could be used to control this infection.

“Antibiotic treatment with piperadiazole reduced the incidence of pneumonia in this group of patients, while it reduced the rate and severity of infection,” said the study.

It also found antimicrobial drugs had the same effect in patients with pneumonia, but were less effective than the antibiotics in treating other types of pneumonia.

“These results provide new evidence to support the use and use of antibiotics for managing bacterial infections,” said Dr. Kranzes co-authors, Dr. Robert T. Jones, of the University at Buffalo and Dr. Paul J. Caffrey, of Harvard Medical School.

“Although antibiotics are generally not used to treat burns, there are cases in which they can be helpful to patients,” he added.

The National Institutes of Health is one of the principal research and development agencies of the United States Department of Health and Human Services.

It supports research on infectious diseases and healthcare technology.